Skip to main content
HLB INC. logo

HLB INC. — Investor Relations & Filings

Ticker · 028300 ISIN · KR7028300002 LEI · 988400ZL885PLZG8E576 KO Manufacturing
Open in API
Filings indexed 555 across all filing types
Latest filing 2020-06-08 Major Shareholding Noti…
Country KR South Korea
Listing KO 028300

About HLB INC.

https://www.hlb.global/

HLB INC. is a biopharmaceutical company focused on developing new global anti-cancer drugs. The company's core activities center on advancing a pipeline of novel therapeutics through its worldwide network, which includes subsidiaries like Elevar Therapeutics and Immunomic Therapeutics. In addition to its primary focus on oncology, HLB's affiliated companies are involved in other life science areas, such as developing and manufacturing in vitro diagnostic medical devices, peptide-based biomaterials, and quasi-drugs. The group also has operations in composite materials and shipbuilding, reflecting its diversified origins.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership (due to rights offerings and stock collateral extensions), and the purpose of holding (management influence) by the major shareholder (Jin Yang-gon) and his special related parties. This is a classic 'Major Shareholding Notification' filing.
2020-06-08 Korean
[기재정정]증권발행실적보고서
Share Issue/Capital Change Classification · 100% confidence The document is a '증권발행실적보고서' (Report on the Results of Securities Issuance), which is a formal regulatory filing in South Korea (DART system) detailing the final results of a capital increase (rights offering). It includes specific sections on issuance overview, subscription results, changes in major shareholdings, and the use of proceeds. This document is a post-issuance report required by financial regulators, fitting the 'Regulatory Filings' category as it is a specific statutory report that does not fall into the other provided categories like 10-K or Earnings Release.
2020-06-08 Korean
전환가액의조정(제32회차)
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) system regarding the adjustment of the conversion price for convertible bonds (CB) due to a bonus issue (free capital increase). This type of disclosure is a standard corporate action related to capital structure and financing instruments. Since it specifically details the adjustment of conversion prices and the resulting change in the number of convertible shares, it falls under the 'Capital/Financing Update' category.
2020-06-08 Korean
전환가액의조정(제33회차)
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing from HLB regarding the adjustment of the conversion price for its 33rd series convertible bonds due to a bonus issue (free capital increase). This type of disclosure, which details changes to the capital structure and conversion terms of financial instruments, falls under the category of capital and financing updates.
2020-06-08 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details the shareholding status of BlackRock Fund Advisors and its special related parties in HLB Co., Ltd. This document type is specifically used to notify the market when a major shareholder crosses a significant ownership threshold. In the provided taxonomy, this corresponds to a Major Shareholding Notification.
2020-06-05 Korean
증권발행결과(자율공시)(주주배정 유상증자)
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing from HLB (에이치엘비) titled '증권 발행결과' (Securities Issuance Results) regarding a paid-in capital increase (주주배정 유상증자). It details the number of shares issued, the total amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2020-06-05 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.